PT Sejahteraraya Anugrahjaya Tbk operates hospitals and offers health care services. It operates and offers medical centers, which include neuroscience, Uro-nephrology, obstetrics and gynecology, cardiovascular, orthopedic, pediatric, oncology, immunology, pulmonology, and internal medicine. The company's operating segments are Inpatient, Medicines, Laboratory, Polyclinic, Radiology, Medical check-up, Pharmacy, Hemodialysis, and Discount for patients, of which prime revenue is derived from the Inpatient segment.
1991
3.0K+
LTM Revenue n/a
LTM EBITDA n/a
$2.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mayapada Hospital has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Mayapada Hospital achieved revenue of $189M and an EBITDA of $15.2M.
Mayapada Hospital expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Mayapada Hospital valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $150M | $189M | XXX | XXX | XXX |
Gross Profit | $33.5M | $43.1M | XXX | XXX | XXX |
Gross Margin | 22% | 23% | XXX | XXX | XXX |
EBITDA | $13.2M | $15.2M | XXX | XXX | XXX |
EBITDA Margin | 9% | 8% | XXX | XXX | XXX |
Net Profit | -$2.7M | -$2.3M | XXX | XXX | XXX |
Net Margin | -2% | -1% | XXX | XXX | XXX |
Net Debt | $36.5M | $68.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Mayapada Hospital's stock price is IDR 2600 (or $0).
Mayapada Hospital has current market cap of IDR 31.82T (or $1.9B), and EV of IDR 33.21T (or $2.0B).
See Mayapada Hospital trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.0B | $1.9B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Mayapada Hospital has market cap of $1.9B and EV of $2.0B.
Mayapada Hospital's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Mayapada Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Mayapada Hospital and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.0B | XXX | XXX | XXX |
EV/Revenue | 10.5x | XXX | XXX | XXX |
EV/EBITDA | 130.9x | XXX | XXX | XXX |
P/E | -1353.3x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -128.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMayapada Hospital's NTM/LTM revenue growth is n/a
Mayapada Hospital's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $15K for the same period.
Over next 12 months, Mayapada Hospital's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Mayapada Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Mayapada Hospital and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 26% | XXX | XXX | XXX | XXX |
EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $15K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 24% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mayapada Hospital acquired XXX companies to date.
Last acquisition by Mayapada Hospital was XXXXXXXX, XXXXX XXXXX XXXXXX . Mayapada Hospital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Mayapada Hospital founded? | Mayapada Hospital was founded in 1991. |
Where is Mayapada Hospital headquartered? | Mayapada Hospital is headquartered in Indonesia. |
How many employees does Mayapada Hospital have? | As of today, Mayapada Hospital has 3.0K+ employees. |
Is Mayapada Hospital publicy listed? | Yes, Mayapada Hospital is a public company listed on IDX. |
What is the stock symbol of Mayapada Hospital? | Mayapada Hospital trades under SRAJ ticker. |
When did Mayapada Hospital go public? | Mayapada Hospital went public in 2011. |
Who are competitors of Mayapada Hospital? | Similar companies to Mayapada Hospital include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Mayapada Hospital? | Mayapada Hospital's current market cap is $1.9B |
What is the current revenue growth of Mayapada Hospital? | Mayapada Hospital revenue growth between 2023 and 2024 was 26%. |
Is Mayapada Hospital profitable? | Yes, Mayapada Hospital is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.